Both the Texas Orthopaedic Association (TOA) and American Academy of Orthopaedic Surgeons (AAOS) have addressed the opioid crisis at recent meetings.
Austin orthopaedic surgeon David Ring, MD, PhD presented at TOA’s 2017 Annual Conference: “The Opioid Crisis: The Future Role of Orthopaedic Surgeons in Solving the Crisis.”
Dr. Ring shared a pain relief video at the conference:
AAOS has produced a pain relief toolkit that orthopaedic surgeons may find to be valuable.
In addition, AAOS created a preoperative screening questionnaire.
The Texas Legislature passed legislation in May 2017 that will require orthopaedic surgeons to check the state’s prescription drug monitoring database (PDMP) for controlled substances beginning on September 1, 2019. TOA expects to work with policymakers on this issue in the months leading up to the 2019 Texas Legislature.
TOA’s Prescription Monitoring Program Recommendation
A special committee of the Texas Legislature chaired by State Senator Charles Schwertner, MD and State Representative JD Sheffield, DO met on October 3, 2018 to review the state’s prescription monitoring program (PMP). Click here to view TOA’s position paper.
Medical Societies Push for PMP Funding
TOA and other medical societies are encouraging the 2019 Texas Legislature to provide funding for the Texas State Board of Pharmacy to acquire licenses for physicians to check the prescription monitoring program.
Click here to learn more.
TOA Makes Recommendations for Enhancing Opioid Safety
TOA presented ideas for making opioids safer for Texans at a March 21, 2019, Texas House committee hearing. Click here to learn more about the five bills that were discussed.
TOA Encourages the Texas Medical Board to Seek Legislative Intent on Opioid CME Bills
The Texas Orthopaedic Association (TOA) supported legislative efforts in the 2019 Texas Legislature to require continuing medical education (CME) for prescribing opioids. TOA was pleased that lawmakers worked with TOA on the issue. Click here to learn more.
Texas Medical Board Offers Guidance Related to the State’s New Opioid Law
Click here or on the graphic below to view.